levodopa

The panel discussing Parkinson’s Progression Marker Initiative at the MJFF’s Parkinson’s Disease Therapeutics Conference in New York. From implanting cells into the brain to prevent the loss of dopamine producing...

Over the last year, three promising new treatments for symptoms of Parkinson’s became available in the United States, but progress has been less hopeful on the development of drugs to...

At an annual conference last month sponsored by the Michael J. Fox Foundation, scientists, academics and business representatives gathered in New York City to explore some of the latest and...